Ren Xiaohui, Cui Yong, Yang Chuanwei, Jiang Zhongli, Lin Song, Lin Zhiqin
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Front Oncol. 2021 Nov 25;11:781396. doi: 10.3389/fonc.2021.781396. eCollection 2021.
Trapped temporal horn (TTH) is a localized hydrocephalus that can be treated with cerebrospinal fluid diversion. Refined temporal-to-frontal horn shunt (RTFHS) through the parieto-occipital approach is rarely reported in the literature and its effectiveness remains unclear. The aim of the present study is to investigate the efficacy and outcome of RTFHS for treatment of TTH.
We consecutively enrolled 10 patients who underwent RTFHS for TTH after surgical resection of peri- or intraventricular tumors from February 2018 to March 2021. Clinical, radiological, and follow-up data were collected and analyzed. The most common underlying pathology was meningioma (n=4), followed by central neurocytoma (n=3), thalamic glioblastoma (n=2), and anaplastic ependymoma (n=1).
The mean Karnofsky performance scale (KPS) score and TTH volume at onset were 54.0 ± 15.1 (range 40-80) and 71.3 ± 33.2cm (range 31.7-118.6cm), respectively. All patients (10/10, 100.0%) presented with periventricular brain edema (PVBE), while midline shift was observed in 9 patients (9/10, 90.0%). RTFHSs were implanted using valveless shunting catheters. No patients developed acute intracranial hemorrhage or new neurological deficit postoperatively. During the follow-up of 17.2 ± 13.7 months (range 3-39 months), all patients showed clinical and radiological improvement. The mean KPS score at the last follow-up was significantly increased to 88.0 ± 10.3 (range 70-100, p<0.0001). RTFHS resulted in significant complete remission in PVBE and midline shift in 8 (80.0%, p=0.0007) and 9 (100.0%, p=0.0001) patients, respectively. As the postoperative follow-up duration prolonged, the mean TTH volume decreased in a consistent, linear trend (p<0.0001). At last follow-up, the mean TTH volume was significantly reduced to 15.4 ± 11.5 cm (range 5.6-44.1 cm, p=0.0003), resulting in a mean relative reduction of 77.2 ± 13.1% compared with the volume of TTH at onset. Over drainage was not observed during the follow-up. No patient suffered from proximal or distal shunt obstruction or shunt related infection, and the revision rate was 0%.
RTFHS seems to be safe and effective for the treatment of TTH with favorable outcomes. Advantages of this technique could be technically less complex and invasive, cost-effective, avoidance of various intraperitoneal complications, and maintaining a near-physiological CSF pathway.
颞角受压(TTH)是一种局限性脑积水,可通过脑脊液分流术进行治疗。经顶枕入路的改良颞叶至额叶角分流术(RTFHS)在文献中报道较少,其有效性尚不清楚。本研究的目的是探讨RTFHS治疗TTH的疗效和结果。
我们连续纳入了10例在2018年2月至2021年3月期间因脑室周围或脑室内肿瘤手术切除后接受RTFHS治疗TTH的患者。收集并分析了临床、影像学和随访数据。最常见的基础病理是脑膜瘤(n = 4),其次是中枢神经细胞瘤(n = 3)、丘脑胶质母细胞瘤(n = 2)和间变性室管膜瘤(n = 1)。
发病时的平均卡氏功能状态量表(KPS)评分和TTH体积分别为54.0±15.1(范围40 - 80)和71.3±33.2cm(范围31.7 - 118.6cm)。所有患者(10/10,100.0%)均出现脑室周围脑水肿(PVBE),9例患者(9/10,90.0%)观察到中线移位。使用无阀分流导管植入RTFHS。术后无患者发生急性颅内出血或新的神经功能缺损。在17.2±13.7个月(范围3 - 39个月)的随访期间,所有患者均显示出临床和影像学改善。最后一次随访时的平均KPS评分显著提高至88.0±10.3(范围70 - 100,p<0.0001)。RTFHS分别使8例(80.0%,p = 0.0007)和9例(100.0%,p = 0.0001)患者的PVBE和中线移位显著完全缓解。随着术后随访时间延长,平均TTH体积呈一致的线性下降趋势(p<0.0001)。在最后一次随访时,平均TTH体积显著降至15.4±11.5 cm(范围5.6 - 44.1 cm,p = 0.0003),与发病时TTH体积相比,平均相对减少77.2±13.1%。随访期间未观察到过度引流。无患者发生近端或远端分流梗阻或分流相关感染,翻修率为0%。
RTFHS治疗TTH似乎安全有效,预后良好。该技术的优点可能是技术上复杂性和侵入性较低、成本效益高、避免各种腹腔内并发症以及维持接近生理的脑脊液通路。